About Curever Pharma Private Limited
Data last updated:
Curever Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Entero Healthcare Solutions Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2021PTC353725. Its GSTIN is 27AAJCC2393N1Z4 (Maharashtra). The company holds 10 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Srivastava and Kaushik Balakrishnan Natesan.
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.8 Lakh, a decline of 79% compared to the previous year. For the same year it recorded a net profit of ₹41.67 Cr and EBITDA of ₹45.54 Cr. Revenue has declined at a compounded annual rate (CAGR) of 68% over three years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Curever. As per MCA filings, the company has satisfied charges of ₹20 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
For more details, the company can be reached via its website curever.com.
Company details
Contact details
Curever Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is curever.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address501 Crystal Plaza – 158 Cts No 560B, C.S.T. Road Kalina, Mumbai, Maharashtra, India – 400098
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Curever Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Curever Pharma operates one associated brand: Curever. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focusing on therapy areas like anti-infective and cardio in India. | curever.com |
Business activity
The main business activity of Curever Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curever Pharma Private Limited, buy the company report.
Financials of Curever Pharma Private Limited
FY 2025 filings availableCurever Pharma Private Limited reported revenue of ₹56.8 Lakh (down 79% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over three years, including a 79% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curever Pharma Private Limited, buy the company report.
Board of directors of Curever Pharma Private Limited
Curever Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Srivastava | Director | 04 Oct 2022 | 4 Years 0 Months | Current |
| Kaushik Balakrishnan Natesan | Director | 19 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Curever Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vhealth Lifecare Private Limited | ₹56.84 Lakh (FY 2025) | -36.0% | Warangal, Telangana, India | |||
| Curever Pharma Private Limitedthis company | ₹56.8 Lakh (FY 2025) | ₹41.67 Cr | -79.0% | 14 | Mumbai, Maharashtra, India | |
| Xenetic Healthcare Private Limited | ₹56.66 Lakh (FY 2021) | -41.0% | Pune, Maharashtra, India | |||
| Prolife Pharma Private Limited | ₹56.56 Lakh (FY 2024) | 9.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Curever Pharma Private Limited, buy the company report.
Auditor
Curever Pharma Private Limited is audited by Pratap B. Sheth & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pratap B. Sheth & Co. | FY 2023 | 108140W |
Shareholding
The shareholding of Curever Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Curever Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2022 | 100535387 | Others | ₹20 Cr | Satisfied |
To see the full charge records of Curever Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Curever Pharma Private Limited has 2 court cases on record: 2 filed by Curever Pharma. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against individuals | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed by the company against an individual | Pending |
To see the full case history of Curever Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curever Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curever Pharma Private Limited has a workforce of 14 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
GST
Curever Pharma has 10 GST registrations: 4 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCC2393N1Z4 | Maharashtra | Active | 20 Apr 2021 |
| 06AAJCC2393N1Z8 | Haryana | Active | 01 Mar 2021 |
| 10AAJCC2393N1ZJ | Bihar | Active | 29 Apr 2022 |
| 20AAJCC2393N1ZI | Jharkhand | Active | 11 May 2022 |
To see the full GST registrations and return filing status of Curever Pharma Private Limited, buy the company report.
Recent activity
Curever Pharma Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Prashant Srivastava ceased to be Additional Director on 10 Mar 2023.
Frequently asked questions
Curever Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 January 2021 (5+ years old) and is registered under CIN U24230MH2021PTC353725.
Curever Pharma has 2 current directors:
- Prashant Srivastava - Director
- Kaushik Balakrishnan Natesan - Director
The latest financial statements of Curever Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Curever Pharma is 27AAJCC2393N1Z4, registered in Maharashtra. The company has 10 GST registrations in all, of which 4 are active and 6 are cancelled or inactive. Other active GSTINs include 06AAJCC2393N1Z8 (Haryana), 10AAJCC2393N1ZJ (Bihar), 20AAJCC2393N1ZI (Jharkhand).
The CIN (Corporate Identification Number) of Curever Pharma is U24230MH2021PTC353725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curever Pharma has 2 court cases on record: 2 filed by the company. 2 are pending.
Curever Pharma was incorporated on 19 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Curever Pharma by revenue are Vhealth Lifecare Private Limited, Xenetic Healthcare Private Limited, Prolife Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prashant Srivastava ceased to be Additional Director on 10 Mar 2023. Prashant Srivastava was appointed as Director on 04 Oct 2022. Davinder Bhardwaj ceased to be Additional Director on 05 Sep 2022. Curever Pharma has 6 board changes on record in total.
Curever Pharma can be reached through the website curever.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Curever Pharma is at 501 Crystal Plaza – 158 Cts No 560B, C.S.T. Road Kalina, Mumbai, Maharashtra, India – 400098.